India vs Indonesia: Number of new G2D leprosy cases
India
1,888
in 2024
Indonesia
869
in 2024
India rank
2nd
Indonesia rank
3rd
Number of new G2D leprosy cases over time
- India
- Indonesia
How they compare
India currently reports 1,888 against 869 in Indonesia, a difference of 1,019.
That makes India's figure about 2.2 times Indonesia's.
Across all 13 years both countries report, India has been ahead every year.
India ranks 2nd and Indonesia ranks 3rd of 161 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4,722 | 1,478 | 3,244 | India |
| 2020s | 2,004 | 752.6 | 1,252 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of new g2d leprosy cases, India or Indonesia?
- India, at 1,888 against 869 in Indonesia as of 2024.
- What is the difference in number of new g2d leprosy cases between India and Indonesia?
- 1,019, with India ahead.
- How many years of comparable data are there for India and Indonesia?
- 13 years are reported by both, from 2012 to 2024.
- How do India and Indonesia rank globally for number of new g2d leprosy cases?
- India ranks 2nd and Indonesia ranks 3rd of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of new G2D leprosy cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.